Study guide

8.2 Congenital Heart Disease & Cardiac Conditions

Board Certified Specialist in Pediatric Nutrition CSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 CSP Exam Facts, Format & Fees 1.2 Eligibility & Application Process 1.3 Scoring, Test Day Logistics & Study Strategy

2 Pediatric Growth & Development

2.1 Growth Patterns Across Pediatric Age Bands 2.2 Developmental Milestones & Feeding Skill Acquisition

3 Human Milk & Infant Formulas

3.1 Human Milk & Lactation Management 3.2 Milk Handling, Storage, Donor Milk & Fortification 3.3 Infant & Specialized Formulas

4 Age-Appropriate Nutrition & Foods

4.1 Complementary Feeding & Toddler Nutrition 4.2 School-Age & Adolescent Nutrition

5 Prematurity & the NICU Graduate

5.1 Preterm Nutrition in the NICU 5.2 Post-Discharge Nutrition for Preterm Infants

6 Congenital, Developmental & Metabolic Conditions

6.1 Congenital & Neurodevelopmental Conditions 6.2 Inborn Errors of Metabolism

7 GI Disorders & Food Allergy

7.1 Gastrointestinal Disorders: IBD, Celiac, Short Bowel & GERD 7.2 Food Allergy, FPIES & Eosinophilic Esophagitis

8 Body System & Organ Dysfunction

8.1 Cystic Fibrosis & Respiratory Support 8.2 Congenital Heart Disease & Cardiac Conditions 8.3 Chronic Kidney Disease, Dialysis & Transplant

9 Oncology, Endocrine & Weight-Related Care

9.1 Pediatric Oncology & HSCT Nutrition 9.2 Diabetes Management & Ketogenic Diet Therapy 9.3 Pediatric Overweight & Obesity (AAP 2023 Guideline) 9.4 Eating Disorders, ARFID & Pediatric Feeding Disorder

10 Clinical Status & Health History

10.1 Medical Treatment & Medication History 10.2 Nutrition & Supplementation History 10.3 Cultural & Psychosocial Factors 10.4 Activity & Lifestyle History 10.5 Birth, Perinatal & Surgical History

11 Anthropometrics & Growth Assessment

11.1 Anthropometric Measurement Techniques 11.2 Growth Charts & Z-Score Interpretation 11.3 Growth Assessment in Preterm & Special Populations 11.4 Pediatric Malnutrition: AND/ASPEN Consensus Criteria 11.5 Body Composition Assessment in Children

12 Physical Exam, Laboratory Data & Nutrition Diagnosis

12.1 Nutrition-Focused Physical Exam 12.2 Diagnostic & Laboratory Testing 12.3 Micronutrient Status Assessment & Deficiency Workup 12.4 Gastrointestinal Function & Diagnostic Testing 12.5 Nutrition Diagnosis, PES Statements & the NCP

13 Estimation of Nutritional Needs

13.1 Energy Needs Across Age & Clinical State 13.2 Protein & Fluid Requirements 13.3 Micronutrient Needs & Catch-Up Growth 13.4 Estimating Needs in Critical Illness & Special Clinical States

14 Oral Nutrition & Supplementation

14.1 Oral Nutrition & Therapeutic Diet Modification 14.2 Texture Modification & Dysphagia Management 14.3 Vitamin & Mineral Supplementation

15 Enteral Nutrition Support

15.1 Enteral Nutrition: Indications & Access 15.2 Enteral Formula Selection 15.3 Feeding Regimens, Advancement & Complications

16 Parenteral Nutrition Support

16.1 PN Indications & Composition 16.2 PN Initiation, Advancement & Monitoring 16.3 PN Complications & IFALD

17 Care Planning, Coordination & Education

17.1 Monitoring & Evaluation of Nutrition Care 17.2 Interdisciplinary Coordination & Transitions of Care 17.3 Access to Food & Healthcare: Federal Programs 17.4 Education & Counseling for Children & Families 17.5 Documentation, Quality & Outcomes in Pediatric Nutrition Care 17.6 Ethics, Palliative Care & Nutrition Decision-Making

8.2 Congenital Heart Disease & Cardiac Conditions

Key Takeaways Explain This Topic AI

Growth failure in congenital heart disease reflects increased energy expenditure (heart failure, tachypnea), decreased intake (feeding fatigue), and malabsorption (splanchnic hypoperfusion).

Breast milk or formula is concentrated to 24-30 kcal/oz for infants with CHD, using precise recipe math and tolerance monitoring.

Oral feeds should be limited to about 20-30 minutes per attempt; fatigue beyond that burns more calories than it delivers, and NG supplementation is indicated for failure to thrive.

Postoperative chylothorax is managed with a medium-chain triglyceride-enriched, low long-chain-fat diet (or skimmed human milk) for approximately 6 weeks.

Calcineurin inhibitors (tacrolimus, cyclosporine) interact with grapefruit via CYP3A4, and corticosteroids drive appetite gain, hyperglycemia, bone loss, and growth suppression.

Last updated: August 2026

Why Infants with Congenital Heart Disease Fail to Thrive

Congenital heart disease (CHD) produces growth failure through three overlapping mechanisms. First, increased energy expenditure : heart failure and tachypnea raise resting metabolic rate, and the work of feeding itself becomes costly. Second, decreased intake : infants fatigue mid-feed, become tachypneic at the breast or bottle, and stop before meeting needs. Third, malabsorption and gut dysfunction : reduced splanchnic perfusion, elevated central venous pressure, and (in Fontan physiology) protein-losing enteropathy impair nutrient absorption. Lesions with pulmonary overcirculation (large ventricular septal defects, single-ventricle physiology) are the highest-risk feeding phenotypes.

  • Mechanism Driver Nutrition response
  • Increased expenditure Heart failure, tachypnea, work of breathing Concentrate feeds to 24-30 kcal/oz
  • Decreased intake Feeding fatigue, tachypnea, early satiety Small frequent feeds, 20-30 min limit, NG top-offs

Malabsorption Splanchnic hypoperfusion, venous congestion Hydrolyzed/MCT-containing formula if needed; monitor stooling

Calorie Concentration and Feeding Management

Standard breast milk and formula provide 20 kcal/oz (0.67 kcal/mL) ; infants with CHD typically need 24-30 kcal/oz . Breast milk is fortified with powdered formula or human milk fortifier; formula is concentrated by adjusting the powder-to-water ratio. Concentration requires careful recipe math : each step raises osmolality and renal solute load, so increases are made gradually (e.g., 22, 24, 26 kcal/oz) while monitoring tolerance — emesis, stool pattern, abdominal distension — and hydration status.

Feeding technique matters as much as the recipe. Offer smaller, more frequent feeds , choose nipple flows that limit work, and cap each oral attempt at about 20-30 minutes — beyond that, the infant expends more energy feeding than the feed provides. When oral intake cannot sustain growth velocity, nasogastric (NG) supplementation (bolus or overnight continuous) is standard; nasojejunal (NJ) feeds are reserved for significant reflux or aspiration risk. Prolonged tube feeding warrants early occupational/speech therapy to prevent oral aversion .

Fluid, Sodium, and Diuretics

Fluid restriction in heart failure creates a dilemma in infants: limiting volume limits nutrition, so the answer is usually to concentrate the feed rather than restrict calories. Loop diuretics such as furosemide waste potassium and can cause hypokalemia , hyponatremia , hypochloremic metabolic alkalosis, and (chronically) hypercalciuria with nephrocalcinosis; potassium supplementation or a potassium-sparing agent is often needed. Thiazides add further sodium and potassium losses. Monitor electrolytes regularly and remember that hyponatremia in CHD is usually dilutional — managed with fluid strategy, not salt loading.